Oryzon to present at upcoming international conferences
MADRID, SPAIN and CAMBRIDGE MA.
• 6th World CNS Summit: Targeting Neurodegeneration, Boston US
• 11th Annual European Life Sciences CEO Forum in Zurich Switzerland
• 30th Annual ROTH Conference in Dana Point, California US
• Alzheimer’s disease AAT-AD/PD 2018 Focus Meeting in Torino Italy
Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international reputed conferences.
Click here to see the full Press Release